前沿生物拟推2025年限制性股票激励计划

Group 1 - The core point of the article is that Frontier Biotech (688221.SH) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant 5 million restricted shares, which accounts for approximately 1.33% of the company's total share capital as of the announcement date [1] - The plan includes an initial grant of 4.25 million restricted shares and reserves 750,000 shares for future grants [1] - The grant price for the initial restricted shares is set at 8.56 yuan per share [1] Group 2 - The effective period of the incentive plan is from the date of grant until all granted restricted shares are vested or become invalid, with a maximum duration of 36 months [1]